share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股sec公告 ·  06/12 09:56
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/12/2024, with an aggregate market value of $1,089,840. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on two separate dates, 02/10/2024 and 02/17/2024, totaling 864 and 1,416 shares respectively. This planned transaction follows a previous sale of the same number of shares on 05/29/2024, which grossed $1,015,876.80. The notice of the upcoming sale was filed on the same day as the planned sale date, with the instruction for the sale given earlier on 02/27/2024.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/12/2024, with an aggregate market value of $1,089,840. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on two separate dates, 02/10/2024 and 02/17/2024, totaling 864 and 1,416 shares respectively. This planned transaction follows a previous sale of the same number of shares on 05/29/2024, which grossed $1,015,876.80. The notice of the upcoming sale was filed on the same day as the planned sale date, with the instruction for the sale given earlier on 02/27/2024.
Vertex Pharmaceuticals Inc. 官员Carmen Bozic计划于2024年06月12日卖出2,280股普通股,市场价值为$1,089,840。这些股票是在2024年02月10日和02月17日两个不同日期根据补偿计划获得的限制性股票。此次计划的交易是在之前于2024年5月29日卖出相同数量股票且总共净赚$1,015,876.80后进行的。这次交易计划的通知与卖出指令均在2024年02月27日之前提出。
Vertex Pharmaceuticals Inc. 官员Carmen Bozic计划于2024年06月12日卖出2,280股普通股,市场价值为$1,089,840。这些股票是在2024年02月10日和02月17日两个不同日期根据补偿计划获得的限制性股票。此次计划的交易是在之前于2024年5月29日卖出相同数量股票且总共净赚$1,015,876.80后进行的。这次交易计划的通知与卖出指令均在2024年02月27日之前提出。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息